A- — FMP rating1. Form 4: 6 transactions1.
Quick AnswerCVS Health Corporation (CVS) Q4 consensus: revenue $107.2B1, EPS $1.171. 8 consecutive quarters of beat1.
Content generated by AI editorial engine. Written by Stock Expert AI's research desk with AI assistance. Figures come from FMP data and the official sources cited in the article.
The median of 10 price targets is $1121, stock is $84, +33.6% vs the analyst consensus median.
A- — FMP rating1. Form 4: 6 transactions1.
Quick AnswerCVS Health Corporation (CVS) Q4 consensus: revenue $107.2B1, EPS $1.171. 8 consecutive quarters of beat1.
Next report
Watchlist
Healthcare Benefits Margin Recovery
Healthcare Benefits delivered $900 million of adjusted operating income in Q3 with a medical benefit ratio of 91.3%.
"In the quarter, we delivered adjusted operating income of $900 million an increase of nearly $600 million from the prior year quarter. Our medical benefit ratio was 91.3%."
- Brian O. Newman, CFO - Q3 FY26 Earnings Call - November 4, 2026
Fy26 Eps Guidance Raise
CVS raised its full-year 2026 adjusted EPS guidance to at least $8.20 from a prior range of $7.90 to $8.10.
David Joyner, Chairman and CEO - Q3 FY26 Earnings Call - November 4, 2026Fy27 Eps Outlook
Management expects at least $8.65 of adjusted EPS in 2027, about 13% growth off an adjusted 2026 baseline.
Brian O. Newman, CFO - Q3 FY26 Earnings Call - November 4, 2026Health Services 2027 Floor
Health Services is expected to deliver at least $7 billion of adjusted operating income in 2027, which management frames as trough earnings for the segment.
Brian O. Newman, CFO - Q3 FY26 Earnings Call - November 4, 2026Q3 Adjusted Eps
Q3 adjusted EPS of $2.09 rose more than 30% from the prior-year quarter.
Brian O. Newman, CFO - Q3 FY26 Earnings Call - November 4, 2026Separation Announcement
CVS Health announced its intention to separate into two independent publicly traded companies: a healthcare solutions company and CVS Pharmacy.
"Today, announced our intention to separate into 2 independent publicly traded companies."
- David Joyner, Chairman and CEO - Q3 FY26 Earnings Call - November 4, 2026
Stock Expert AI - Methodology
Historical V1 earnings-model score (archived, Nov 8, 2026) — not the current MoonshotScore. Current MoonshotScore: CVS stock page
multi-pillar methodology. Cash Runway and News Sentiment strong. Revenue Growth weak.
How is it calculated? ->6 investor frameworks. 4 bullish (Ray Dalio, Klarman, Buffett, Munger), 1 bearish (Ken Griffin), 1 neutral (Jim Simons).
How is it calculated? ->Quality business, discounted price.
How is it calculated? ->Past Performance
Brian O. Newman].
No RPO/backlog concentration disclosed in Q3 earnings call.
Form 4 Q3 FY26: 6 transactions, net -$280.77M1.
6 transactions · 5 sales / 1 purchases = net negative flow. Not large in absolute terms against a $107.2B market cap.
Not advice - a structural framework for earnings night. Decision discipline is yours.
Market Outlook
You read it in 5 minutes. When the numbers come out on Tuesday evening - you know what you're looking at.
Data arrives at night. The framework is ready now.
Data arrives on Tuesday evening. The framework is ready on this page: Q4 EPS threshold $1.171, CapEx threshold "below $817.0M". Two anchors, three scenarios.
Comparison Stock Expert AI is free today — no credit card.
Seeking Alpha $299/yr - analyst opinions + earnings coverage TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts
Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing
Stock Expert AI is free today — no credit card. Council 6-lens analysis + MoonshotScore multi-pillar + Insider tracker + Technical levels - all in one platform, for every stock.
Educational tool, not investment advice. Past performance does not guarantee future results.
Calendar
DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.
This CVS Health Corporation (CVS) Q4 FY26 earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.
CVS Health Corporation (CVS): Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.
CVS Health Corporation (CVS): Figures are sourced from Financial Modeling Prep (FMP) fundamentals and consensus data plus official earnings-call transcripts; derived metrics are labeled with their source next to each figure.
CVS Health Corporation (CVS): No. This page is educational research, not investment advice. It summarizes analyst consensus and company data; consult a licensed financial advisor before making any investment decision.